A federal judge raised the prospect of not approving CVS Health’s deal to buy insurer Aetna, which closed earlier this week, during a routine portion of the legal process.
Judge Richard Leon of the US District Court for the District of Columbia objected to what he said was the government’s and companies’ treatment of him as a “rubber stamp” for the deal, noting that CVS had closed its deal to buy Aetna for US$69 billion on Wednesday, November 28.
The judge, in a brief hearing Monday, said he’s considering requiring that the merged firm hold the CVS and Aetna assets separate until he has more time to consider the settlement. If he does so, it could cause considerable disruptions for the newly merged firm, as CVS began integrating Aetna’s assets immediately after the deal closed last week.
Aetna said in a statement, “It’s commonplace for acquisitions to close before this final step in the process is complete, and our focus remains on delivering on the combined company’s potential.” CVS did not return a request for comment.
Full Content: Wall Street Journal
Featured News
UK Regulator Proposes State-Backed Formula to Lower Baby Formula Costs
Nov 10, 2024 by
CPI
Justice Department Probes Alleged Price-Fixing in PVC Pipe Industry
Nov 10, 2024 by
CPI
US Imposes Ban on TSMC’s Advanced Chip Exports to China Amid AI Concerns
Nov 10, 2024 by
CPI
Vanderbilt QB Sues NCAA Over Junior College Eligibility Rules
Nov 10, 2024 by
CPI
Trump’s Transition Team Prepares to Reshape FTC Leadership and Antitrust Agenda
Nov 10, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI